Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Lung Cancer

Free Subscription Articles published in Carcinogenesis Retrieve available abstracts of 42 articles: HTML format

Single Articles

March 2024
1. VISONA SD, Bertoglio B, Capella S, Belluso E, et al
   Asbestos burden in lungs of mesothelioma patients with pleural plaques, lung fibrosis and/or ferruginous bodies at histology: a postmortem SEM-EDS study.
   Carcinogenesis. 2024;45:131-139.
   PubMed     Abstract available
   
   
   December 2023
2. KANG G, Jiao Y, Pan P, Fan H, et al
   alpha5-nAChR/STAT3/CD47 axis contributed to nicotine-related lung adenocarcinoma progression and immune escape.
   Carcinogenesis. 2023;44.
   PubMed     Abstract available
   
   
   
3. MOHAMED E, Garcia Martinez DJ, Hosseini MS, Yoong SQ, et al
   Identification of biomarkers for the early detection of non-small cell lung cancer: a systematic review and meta-analysis.
   Carcinogenesis. 2023 Dec 8:bgad091. doi: 10.1093.
   PubMed     Abstract available
   
   
   August 2023
4. BLECHTER B, Wong JYY, Hu W, Cawthon R, et al
   Exposure to smoky coal combustion emissions and leukocyte Alu retroelement copy number.
   Carcinogenesis. 2023;44:404-410.
   PubMed     Abstract available
   
   
   June 2023
5. BAGHERPOOR AJ, Shameem M, Luo X, Seelig D, et al
   Inhibition of lung adenocarcinoma by combinations of sulfasalazine (SAS) and disulfiram-copper (DSF-Cu) in cell line models and mice.
   Carcinogenesis. 2023;44:291-303.
   PubMed     Abstract available
   
   
   May 2023
6. PU J, Teng Z, Yang W, Zhu P, et al
   Construction of a prognostic model for lung squamous cell carcinoma based on immune-related genes.
   Carcinogenesis. 2023;44:143-152.
   PubMed     Abstract available
   
   
   
7. CHEN J, Li J, Sun H, Hu T, et al
   PPM1G promotes the progression of lung adenocarcinoma by inhibiting p38 activation via dephosphorylation of MEK6.
   Carcinogenesis. 2023;44:93-104.
   PubMed     Abstract available
   
   
   
8. OTA K, Sakai S, Ohhata T, Suzuki T, et al
   APOBEC3B expression is promoted by lincNMR collaborating with TGF-beta-Smad pathway.
   Carcinogenesis. 2023;44:1-14.
   PubMed     Abstract available
   
   
   
9. TANG Q, Zhou Q, Li J, Yang X, et al
   Solamargine enhanced gefitinib anti-tumor effect via regulating MALAT1/miR-141-3p/Sp1/IGFBP1 signaling pathway in non-small cell lung cancer.
   Carcinogenesis. 2023 May 5:bgad028. doi: 10.1093.
   PubMed     Abstract available
   
   
   April 2023
10. ZHANG Y, Liu X, Dang W, Liu L, et al
    Thymoquinone inhibits lung cancer stem cell properties via triggering YAP degradation.
    Carcinogenesis. 2023 Apr 27:bgad026. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2022
11. LI S, Chen Z, Zhang W, Wang T, et al
    Elevated expression of the membrane-anchored serine protease TMPRSS11E in NSCLC progression.
    Carcinogenesis. 2022;43:1092-1102.
    PubMed     Abstract available
    
    
    October 2022
12. ZHAO L, Lei J, Gu S, Zhang Y, et al
    A yes-associated protein 1-Notch1 positive feedback loop promotes breast cancer lung metastasis by attenuating the Bone morphogenetic protein 4-SMAD family member 1/5 signaling.
    Carcinogenesis. 2022 Oct 4. pii: 6748174. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2022
13. LU F, Zhou J, Chen Q, Zhu J, et al
    PSMA5 contributes to progression of lung adenocarcinoma in association with the JAK/STAT pathway.
    Carcinogenesis. 2022;43:624-634.
    PubMed     Abstract available
    
    
    
14. SATOH H, Arai Y, Furukawa E, Moriguchi T, et al
    Genomic landscape of chemical-induced lung tumors under Nrf2 different expression levels.
    Carcinogenesis. 2022;43:613-623.
    PubMed     Abstract available
    
    
    
15. BIAN T, Ding H, Wang Y, Hu Q, et al
    Suppressing the activation of protein kinase A as a DNA damage-independent mechanistic lead for dihydromethysticin prophylaxis of NNK-induced lung carcinogenesis.
    Carcinogenesis. 2022;43:659-670.
    PubMed     Abstract available
    
    
    June 2022
16. KASSIE F, Bagherpoor AJ, Kovacs K, Seelig D, et al
    Combinatory lung tumor inhibition by myo-inositol and iloprost/rapamycin: association with immunomodulation.
    Carcinogenesis. 2022;43:547-556.
    PubMed     Abstract available
    
    
    
17. FENG J, Ouyang H, Wang J, Pan D, et al
    MPZL1 upregulation promotes tumor metastasis and correlates with unfavorable prognosis in non-small cell lung cancer.
    Carcinogenesis. 2022 Jun 21. pii: 6612224. doi: 10.1093.
    PubMed     Abstract available
    
    
    
18. ZHAO A, Li F, Wei C, Zhou Z, et al
    TNFalpha antagonist in combination with PD-1 blocker to prevent or retard malignant transformation of B[a]P-induced chronic lung inflammation.
    Carcinogenesis. 2022;43:445-456.
    PubMed     Abstract available
    
    
    May 2022
19. YOON HS, Shu XO, Cai H, Zheng W, et al
    Associations of Lung Cancer Risk with Biomarkers of Helicobacter pylori Infection.
    Carcinogenesis. 2022 May 24. pii: 6590911. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2022
20. HU Q, Upadhyaya P, Hecht SS, Aly FZ, et al
    Characterization of adductomic totality of NNK, (R)-NNAL and (S)-NNAL in A/J mice, and their correlations with distinct lung carcinogenicity.
    Carcinogenesis. 2022;43:170-181.
    PubMed     Abstract available
    
    
    February 2022
21. MENG Z, Zhang R, Wu X, Zhang M, et al
    Prognostic value of Mortalin correlates with roles in epithelial-mesenchymal transition and angiogenesis in lung adenocarcinoma.
    Carcinogenesis. 2022;43:40-51.
    PubMed     Abstract available
    
    
    January 2022
22. ZHANG Q, Jia Y, Pan P, Zhang X, et al
    alpha5-nAChR associated with Ly6E modulates cell migration via TGF-beta1/Smad signaling in non-small cell lung cancer.
    Carcinogenesis. 2022 Jan 5. pii: 6498141. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2021
23. DONNELLY LL, Hogan TC, Lenahan SM, Nandagopal G, et al
    Functional assessment of somatic STK11 variants identified in primary human non-small cell lung cancers.
    Carcinogenesis. 2021;42:1428-1438.
    PubMed     Abstract available
    
    
    
24. XU R, Yan Y, Zheng X, Zhang H, et al
    Aspirin Suppresses Breast Cancer Metastasis to Lung by Targeting Anoikis Resistance.
    Carcinogenesis. 2021 Dec 27. pii: 6484923. doi: 10.1093.
    PubMed     Abstract available
    
    
    
25. YANG L, Wu D, Chen J, Chen J, et al
    Corrigendum to: A functional CNVR_3425.1 damping lincRNA FENDRR increases lifetime risk of lung cancer and COPD in Chinese.
    Carcinogenesis. 2021 Dec 23. pii: 6481929. doi: 10.1093.
    PubMed    
    
    
    
26. LI H, Zhao S, Chen X, Feng G, et al
    MiR-145 modulates the radiosensitivity of non-small cell lung cancer cells by suppression of TMOD3.
    Carcinogenesis. 2021 Dec 9. pii: 6458453. doi: 10.1093.
    PubMed     Abstract available
    
    
    
27. HUDLIKAR RR, Sargsyan D, Cheng D, Kuo HD, et al
    Tobacco carcinogen 4-[Methyl(nitroso)amino]-1-(3-pyridinyl)-1-butanone (NNK) drives metabolic rewiring and epigenetic reprograming in A/J mice lung cancer model and prevention with Diallyl Sulphide (DAS).
    Carcinogenesis. 2021 Dec 9. pii: 6458449. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2021
28. WANG M, Li S, Guo W, Wang L, et al
    CHRAC1 promotes human lung cancer growth through regulating YAP transcriptional activity.
    Carcinogenesis. 2021 Oct 27. pii: 6412599. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2021
29. ANG L, Ghosh P, Seow WJ
    Association between previous lung diseases and lung cancer risk: a systematic review and meta-analysis.
    Carcinogenesis. 2021 Sep 6. pii: 6364950. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2021
30. HE T, Ling F
    CALCR knockdown inhibits the development and progression of non-small-cell lung cancer.
    Carcinogenesis. 2021 Aug 21. pii: 6356050. doi: 10.1093.
    PubMed     Abstract available
    
    
    
31. TAO K, Liu J, Liang J, Xu X, et al
    Vascular endothelial cell-derived exosomal miR-30a-5p inhibits lung adenocarcinoma malignant progression by targeting CCNE2.
    Carcinogenesis. 2021;42:1056-1067.
    PubMed     Abstract available
    
    
    
32. WANG Q, Ru M, Zhang Y, Kurbanova T, et al
    Dietary phytoestrogen intake and lung cancer risk: an analysis of the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial.
    Carcinogenesis. 2021 Aug 9. pii: 6346800. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2021
33. WANG Y, Ji M, Zhu M, Fan J, et al
    Genome-wide gene-smoking interaction study identified novel susceptibility loci for non-small cell lung cancer in Chinese populations.
    Carcinogenesis. 2021 Jul 23. pii: 6326566. doi: 10.1093.
    PubMed     Abstract available
    
    
    
34. CHEN W, Saxton B, Tessema M, Belinsky SA, et al
    Inhibition of GFAT1 in lung cancer cells destabilizes PD-L1 protein.
    Carcinogenesis. 2021 Jul 16. pii: 6322888. doi: 10.1093.
    PubMed     Abstract available
    
    
    
35. LI Z, Pan C, Wang Z, Deng X, et al
    LncRNA PCBP1-AS1 correlated with the functional states of cancer cells and inhibited lung adenocarcinoma metastasis by suppressing the EMT progression.
    Carcinogenesis. 2021;42:931-939.
    PubMed     Abstract available
    
    
    
36. CUI D, Zhu Y, Yan D, Lee NPY, et al
    Dual inhibition of cMET and EGFR by microRNA-338-5p suppresses metastasis of esophageal squamous cell carcinoma.
    Carcinogenesis. 2021;42:995-1007.
    PubMed     Abstract available
    
    
    June 2021
37. XIAN J, Zeng Y, Chen S, Lu L, et al
    Discovery of a novel linc01125 isoform in serum exosomes as a promising biomarker for NSCLC diagnosis and survival assessment.
    Carcinogenesis. 2021;42:831-841.
    PubMed     Abstract available
    
    
    
38. CHEN H, Lu C, Lin C, Li L, et al
    VPS34 suppression reverses osimertinib resistance via simultaneously inhibiting glycolysis and autophagy.
    Carcinogenesis. 2021;42:880-890.
    PubMed     Abstract available
    
    
    April 2021
39. JIANG T, Wu H, Lin M, Yin J, et al
    B4GALNT1 promotes progression and metastasis in lung adenocarcinoma through JNK/c-Jun/Slug pathway.
    Carcinogenesis. 2021;42:621-630.
    PubMed     Abstract available
    
    
    
40. GUI HX, Peng J, Yang ZP, Chen LY, et al
    HDAC1-Smad3-mSin3A complex is required for Smad3-induced transcriptional inhibition of hepatocyte growth factor receptor in human lung cancers.
    Carcinogenesis. 2021;42:587-600.
    PubMed     Abstract available
    
    
    February 2021
41. HAMADA K, Tian Y, Fujimoto M, Takahashi Y, et al
    DNA hypermethylation of the ZNF132 gene participates in the clinicopathological aggressiveness of 'pan-negative'-type lung adenocarcinomas.
    Carcinogenesis. 2021;42:169-179.
    PubMed     Abstract available
    
    
    
42. LI P, Zhang X, Murphy AJ, Costa M, et al
    Downregulation of hedgehog-interacting protein (HHIP) contributes to hexavalent chromium-induced malignant transformation of human bronchial epithelial cells.
    Carcinogenesis. 2021;42:136-147.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.